-Two-Year Follow-Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia. Liga: https://www.ncbi.nlm.nih.gov/pubmed/28341525
